⌘K

Login Start Free

Home/Filings/4/0000882104-12-000013

4//SEC Filing

Tomlinson Bruce 4

Accession 0000882104-12-000013

CIK 0000882104other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:41 PM ET

Size

5.2 KB

Accession

0000882104-12-000013

Insider Transaction Report

Form 4

Period: 2012-06-21

PDL BIOPHARMA, INC.PDLI

Tomlinson Bruce

Chief Financial Officer

Transactions

Award
Common Stock
2012-06-21$6.36/sh+16,509$104,997→ 16,509 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PDL BIOPHARMA, INC.

CIK 0000882104

Entity typeother

Related Parties

1

filerCIK 0001552123

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 6:41 PM ET
Size: 5.2 KB

View on SEC.gov